Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy (ImmunBioProBrachy)

NCT07131956 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT07131956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07131956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy (ImmunBioProBrachy)
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2025
Completion date
July 31, 2028
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis), prostate cancer patients treated by radiotherapy, prostate cancer patients who have brachytherapy seed implant, prostate cancer recurrent